STOCKHOLM (AP) — Jennifer A. Doudna, a Harvard Medical School doctorate, and French scientist Emmanuelle Charpentier have won the Nobel Prize in chemistry for developing a method of genome editing known as CRISPR.
The recipients were announced Wednesday in Stockholm by Goran Hansson, Secretary General of the Royal Swedish Academy of Sciences.
Doudna earned a doctorate in 1989 from Harvard Medical School where Nobel Prize winner Jack W. Szostakwas her academic advisor. In 2016, she and Charpentier were among five recipients of Warren Alpert prize for CRISPR research.
That year, Doudna told a Harvard symposium the medical school was her “scientific home.” “Fundamental, curiosity-driven research is really what underscored and made possible the evolution of this technology,” she said. “It’s exciting and certainly a principle I learned as a student here.”
Doudna is the second scientist with Massachusetts connections to be awarded a Nobel this year.
On Tuesday MIT graduate Andrea Ghez and two other scientists were awarded the Nobel Prize in physics for their research on black holes. Roger Penrose of Britain, Reinhard Genzel of Germany were the other honorees.
On Monday, the Nobel Committee awarded the prize for physiology and medicine to Americans Harvey J. Alter and Charles M. Rice and British-born scientist Michael Houghton for discovering the liver-ravaging hepatitis C virus.
The other prizes are for outstanding work in the fields of literature, peace and economics.
The prestigious award comes with a gold medal and prize money of 10 million krona (more than $1.1 million), courtesy of a bequest left more than a century ago by the prize’s creator, Swedish inventor Alfred Nobel. The amount was increased recently to adjust for inflation.